Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
VBI Vaccines
Pharma
EMA expands nods for BMS, Eli Lilly, Novartis drugs
In an important update for Eli Lilly, EMA's CHMP recommended the use of Verzenios as an adjuvant treatment for HR+/HER2- breast cancer.
Angus Liu
Feb 25, 2022 11:42am
FDA approves VBI's PreHevbrio just as HBV market is set to grow
Dec 1, 2021 10:34am
Heplisav-B; Janssen and more—News of Note
Feb 27, 2019 9:14am
Zika, VBI Vaccines and more—News of Note
Aug 21, 2018 3:25pm
VBI Vaccines touts positive phase 1 data for CMV vaccine
May 15, 2018 8:43am
Vical’s Astellas-partnered CMV vaccine falls short in phase 3
Jan 22, 2018 3:32pm
